Datavault AI Licenses Smart Contracts IP to Wellgistics Health for PharmacyChain Integration
TL;DR
Datavault AI's smart contract licensing gives Wellgistics Health a competitive edge by reducing PBM costs and enhancing transparency across 6,500+ pharmacies.
Datavault AI's smart contracts integrate with PharmacyChain and EinsteinRx platforms using Web 3.0 technology to automate prescription tracking and pharmaceutical distribution.
This partnership modernizes pharmaceutical distribution by improving prescription transparency and reducing healthcare costs, creating a more efficient system for patients and providers.
Datavault AI's Web 3.0 smart contracts now power prescription tracking across 6,500+ pharmacies through Wellgistics' PharmacyChain and EinsteinRx platforms.
Found this article helpful?
Share it with your network and spread the knowledge!
Datavault AI Inc. (NASDAQ: DVLT) has exclusively licensed its proprietary smart contracts intellectual property to Wellgistics Health (NASDAQ: WGRX) for integration into the PharmacyChain™ and EinsteinRx™ platforms. This strategic partnership enables Web 3.0 smart contract functions across a network of more than 6,500 pharmacies, representing a significant advancement in pharmaceutical distribution technology.
The integration supports Wellgistics' comprehensive plan to streamline prescription tracking, reduce Pharmacy Benefit Manager (PBM)-driven costs, enhance transparency for payers, and modernize U.S. pharmaceutical distribution through data automation and AI integration. This collaboration marks a critical step toward transforming how prescription medications are managed and distributed throughout the healthcare ecosystem.
Datavault AI's technology portfolio includes the Information Data Exchange® (IDE), which enables Digital Twins and licensing of name, image, and likeness (NIL) by securely attaching physical real-world objects to immutable metadata objects. This approach fosters responsible AI with integrity while providing comprehensive solutions across multiple industries including healthcare, biotech, and fintech.
The company's cloud-based platform offers AI and Machine Learning (ML) automation, third-party integration, detailed analytics and data, marketing automation and advertising monitoring. These capabilities will be leveraged to enhance Wellgistics' pharmacy platforms, potentially revolutionizing how pharmacies interact with patients, payers, and pharmaceutical manufacturers.
For investors and stakeholders following Datavault AI's developments, the latest news and updates relating to DVLT are available in the company's newsroom at https://ibn.fm/DVLT. The full press release detailing this licensing agreement can be viewed at https://ibn.fm/MLaEZ.
This partnership represents a significant milestone in healthcare technology integration, potentially setting new standards for efficiency and transparency in pharmaceutical distribution. The combination of Datavault AI's Web 3.0 expertise with Wellgistics' extensive pharmacy network could fundamentally change how prescription medications are tracked, managed, and paid for across the United States healthcare system.
Curated from InvestorBrandNetwork (IBN)
